Researchers at The University of Texas MD Anderson Cancer Center have discovered an immune regulator that appears to dictate glioblastoma progression by shutting down immune surveillance, indicating a potential new area of therapeutic investigation.
More From BioPortfolio on "Researchers discover immune regulator that appears to dictate glioblastoma"